Antibodies Against Cd38 For Treatment Of Multiple Myeloma

Patent No. EP3312196 (titled "Antibodies Against Cd38 For Treatment Of Multiple Myeloma") was filed by Genmab on Mar 23, 2006. The application was issued on Jul 17, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
SECERNA	Apr 16, 2020	SECERNA

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jan 27, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jan 27, 2021
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jan 22, 2021
Termination of the opposition proceedings with revocation of patent
Oct 9, 2020
(Electronic) Receipt
Oct 9, 2020
(Electronic) Receipt
Oct 9, 2020
Acknowledgement of a document
Oct 9, 2020
Acknowledgement of a document
Oct 9, 2020
Letter accompanying subsequently filed items
Oct 9, 2020
Letter accompanying subsequently filed items
Oct 6, 2020
Acknowledgement of a document
Oct 6, 2020
Acknowledgement of a document
Oct 6, 2020
Decision revoking the European patent
Oct 6, 2020
Decision revoking the European patent
Sep 24, 2020
(Electronic) Receipt
Sep 24, 2020
Letter accompanying subsequently filed items
Sep 24, 2020
Request for revocation of patent
Jun 22, 2020
Communication of a notice of opposition and request to file observations
Jun 22, 2020
Notice of further oppositions to opponent(s)
Apr 23, 2020
Communication of a notice of opposition - first information to patent proprietor
Apr 17, 2020
Consolidated list of cited opposition documents
Apr 16, 2020
(Electronic) Receipt
Apr 16, 2020
Citation in opposition procedure - 001
Apr 16, 2020
Citation in opposition procedure - 002
Apr 16, 2020
Citation in opposition procedure - 003
Apr 16, 2020
Citation in opposition procedure - 004
Apr 16, 2020
Citation in opposition procedure - 005
Apr 16, 2020
Citation in opposition procedure - 006
Apr 16, 2020
Citation in opposition procedure - 007
Apr 16, 2020
Citation in opposition procedure - 008
Apr 16, 2020
Citation in opposition procedure - 009
Apr 16, 2020
Citation in opposition procedure - 010
Apr 16, 2020
Citation in opposition procedure - 011
Apr 16, 2020
Citation in opposition procedure - 012
Apr 16, 2020
Citation in opposition procedure - 013
Apr 16, 2020
Notice of opposition
Apr 16, 2020
Notice of opposition
Jul 29, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jun 21, 2019
Decision to grant a European patent
May 30, 2019
(Electronic) Receipt
May 30, 2019
Filing of the translations of the claims
May 30, 2019
French translation of claims
May 30, 2019
German translation of the claims
May 30, 2019
Letter accompanying subsequently filed items
Apr 24, 2019
Bibliographic data of the European patent application
Apr 24, 2019
Communication about intention to grant a European patent
Apr 24, 2019
Intention to grant (signatures)
Apr 24, 2019
Text intended for grant (clean copy)
Apr 24, 2019
Text intended for grant (sequence listing)
Apr 24, 2019
Text intended for grant (version for approval)
Apr 5, 2019
(Electronic) Receipt
Apr 5, 2019
Amended description with annotations
Apr 5, 2019
Description
Apr 5, 2019
Letter accompanying subsequently filed items
Apr 5, 2019
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Mar 29, 2019
Bibliographic data of the European patent application
Mar 29, 2019
Communication about intention to grant a European patent
Mar 29, 2019
Intention to grant (signatures)
Mar 29, 2019
Text intended for grant (clean copy)
Mar 29, 2019
Text intended for grant (sequence listing)
Mar 29, 2019
Text intended for grant (version for approval)
Feb 26, 2019
(Electronic) Receipt
Feb 26, 2019
Amended description with annotations
Feb 26, 2019
Description
Feb 26, 2019
Drawings
Feb 26, 2019
Letter accompanying subsequently filed items
Feb 26, 2019
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Dec 14, 2018
Bibliographic data of the European patent application
Dec 14, 2018
Communication about intention to grant a European patent
Dec 14, 2018
Intention to grant (signatures)
Dec 14, 2018
Text intended for grant (clean copy)
Dec 14, 2018
Text intended for grant (sequence listing)
Dec 14, 2018
Text intended for grant (version for approval)
Oct 16, 2018
(Electronic) Receipt
Oct 16, 2018
Amended description with annotations
Oct 16, 2018
Annex
Oct 16, 2018
Annex
Oct 16, 2018
Converted Sequence Listing
Oct 16, 2018
Description
Oct 16, 2018
Letter accompanying subsequently filed items
Oct 16, 2018
Non-patent literature cited during the examination procedure
Oct 16, 2018
Non-patent literature cited during the examination procedure
Oct 16, 2018
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Oct 16, 2018
Sequence listing
Jul 25, 2018
Bibliographic data of the European patent application
Jul 25, 2018
Communication about intention to grant a European patent
Jul 25, 2018
Intention to grant (signatures)
Jul 25, 2018
Text intended for grant (clean copy)
Jul 25, 2018
Text intended for grant (sequence listing)
Jul 25, 2018
Text intended for grant (version for approval)
May 18, 2018
Examination started
May 2, 2018
Information about publication, reminder payment of designation fee, response to extended European search report, if applicable
Apr 20, 2018
(Electronic) Receipt
Apr 20, 2018
Amended claims filed after receipt of (European) search report
Apr 20, 2018
Amended claims with annotations
Apr 20, 2018
Amendments received before examination
Apr 20, 2018
Letter accompanying subsequently filed items
Mar 28, 2018
Notification of forthcoming publication
Feb 14, 2018
Refund of fees
Feb 8, 2018
Communication regarding the transmission of the European search report
Feb 8, 2018
European search opinion
Feb 8, 2018
European search report
Feb 8, 2018
Information on Search Strategy
Jan 25, 2018
Search started
Jan 4, 2018
Communication to designated inventor
Jan 4, 2018
Communication to designated inventor
Jan 4, 2018
Communication to designated inventor
Jan 4, 2018
Communication to designated inventor
Jan 4, 2018
Communication to designated inventor
Jan 4, 2018
Communication to designated inventor
Dec 19, 2017
Communication of the registration of a transfer or change of name and/or address
Dec 14, 2017
(Electronic) Receipt
Dec 14, 2017
Converted Sequence Listing
Dec 14, 2017
Letter accompanying subsequently filed items
Dec 14, 2017
Reply to the invitation to remedy deficiencies
Dec 13, 2017
Submission concerning change of applicant's address
Nov 30, 2017
Deficiencies in sequence listing
Nov 7, 2017
Abstract
Nov 7, 2017
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Nov 7, 2017
Amended claims with annotations
Nov 7, 2017
Claims
Nov 7, 2017
Converted Sequence Listing
Nov 7, 2017
Description
Nov 7, 2017
Designation of inventor
Nov 7, 2017
Drawings
Nov 7, 2017
Letter concerning search matters
Nov 7, 2017
Matter concerning the application
Nov 7, 2017
Request for grant of a European patent
Oct 16, 2006
Priority document (electronically transmitted)
Oct 16, 2006
Priority document (electronically transmitted)
Oct 16, 2006
Priority document (electronically transmitted)
Oct 16, 2006
Priority document (electronically transmitted)

EP3312196

GENMAB

Application Number: EP17200442A
Filing Date: Mar 23, 2006
Status: Revoked; Jan 29, 2021
Publication Date: Jul 17, 2019
External Links: Slate, Register , Google Patents

IP Verse

Antibodies Against Cd38 For Treatment Of Multiple Myeloma

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3312196